NDC 80425-0200-01 - Sertraline Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0200
- Requested NDC
- 80425-0200-01
- Package NDCs from labels
- 80425-0200-1, 80425-0200-2, 80425-0200-3, 80425-0200-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sertraline Hydrochloride - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0200-1 | Sertraline Hydrochloride | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 5 | |
| 80425-0200-2 | Sertraline Hydrochloride | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 5 | |
| 80425-0200-3 | Sertraline Hydrochloride | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0200 | SERTRALINE HYDROCHLORIDE TABLET, FILM COATED [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 5 | Current NDC, Legacy NDC, 3 package rows | 20250101_ec1b68d3-ff55-d0a2-e053-2a95a90a2e0b.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0200-1 | EA - Each | 80425-0200 | 03ef4d3e-014e-4195-8a56-83f4fc89543b | 1 | 2023-04-07 |
| 80425-0200-2 | EA - Each | 80425-0200 | 81a8962a-db14-4883-b4cf-e50f41204f20 | 1 | 2023-06-06 |
| 80425-0200-3 | EA - Each | 80425-0200 | 59e65e04-28a1-446b-9442-df5d1997a83b | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SERTRALINE HYDROCHLORIDE | SERTRALINE HYDROCHLORIDE | A-S Medication Solutions | 45af84f5-c284-4e82-ad3c-e9b7ab2b8114 | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | 312938 UTI8907Y6X |
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 3ca30f3f-545e-46c5-b56a-73ec48e9647f | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | ANDA077206 312938 UTI8907Y6X |
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | AvPAK | 40be43b2-649b-0928-e063-6394a90a3b48 | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | 312938 312940 312941 UTI8907Y6X |
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 91b4c802-9c6b-49bb-b5a7-661e1917ef34 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | ANDA077206 312938 UTI8907Y6X |
| Sertraline | SERTRALINE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 444ca054-e450-4c10-a31b-71ad43946cb8 | 2025-09-09 | Boxed warning, Warnings, Adverse reactions | 312938 312940 312941 UTI8907Y6X |
| sertraline hydrochloride | SERTRALINE HYDROCHLORIDE | Alvogen, Inc. | e0e1f35e-114d-bb39-34f1-70208b94ac9e | 2025-08-06 | Boxed warning, Warnings, Adverse reactions | UTI8907Y6X |
| Sertraline | SERTRALINE | A-S Medication Solutions | ad69cbfe-5b42-4714-a999-77d474e0849d | 2025-07-31 | Boxed warning, Warnings, Adverse reactions | 312940 UTI8907Y6X |
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | Bryant Ranch Prepack | 50d0aef5-ecc7-49b0-964a-53f87058d22a | 2025-07-30 | Boxed warning, Warnings, Adverse reactions | ANDA077206 312941 UTI8907Y6X |
| SERTRALINE | SERTRALINE | Aphena Pharma Solutions - Tennessee, LLC | 1548faf9-8625-f871-e063-6394a90a931f | 2025-07-21 | Boxed warning, Warnings, Adverse reactions | 312941 UTI8907Y6X |
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | Cipla USA Inc. | 3a3efb5f-b24a-438d-9253-371ff3b5417d | 2025-07-16 | Boxed warning, Warnings, Adverse reactions | UTI8907Y6X |
| Sertraline | SERTRALINE | Bryant Ranch Prepack | c67bc43d-d341-47c6-8b81-a7ad4cdb1207 | 2025-06-23 | Boxed warning, Warnings, Adverse reactions | 312940 UTI8907Y6X |
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | Zydus Pharmaceuticals (USA) Inc. | 23f1c8c5-032c-4ea9-beb0-ca3a614ba4b6 | 2025-03-26 | Boxed warning, Warnings, Adverse reactions | UTI8907Y6X |
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 30b94d67-0000-a045-e063-6394a90ade32 | 2025-03-19 | Boxed warning, Warnings, Adverse reactions | 312938 UTI8907Y6X |
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 680890b1-bc45-4f50-9aaf-e730ab515b85 | 2025-03-06 | Boxed warning, Warnings, Adverse reactions | ANDA077206 312938 UTI8907Y6X |
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | Asclemed USA, Inc. | e25a13c3-a173-4cc3-99d3-0be43abbc498 | 2025-02-12 | Boxed warning, Warnings, Adverse reactions | ANDA077206 312938 312940 312941 UTI8907Y6X |
| Sertraline | SERTRALINE | NuCare Pharmaceuticals,Inc. | 0a1f7d44-c339-a4dd-e063-6294a90ac0de | 2025-02-03 | Boxed warning, Warnings, Adverse reactions | 312938 UTI8907Y6X |
| Sertraline hydrochloride | SERTRALINE HYDROCHLORIDE | Coupler LLC | 2ce05049-030f-3e8b-e063-6394a90a4885 | 2025-01-29 | Boxed warning, Warnings, Adverse reactions | 312941 UTI8907Y6X |
| SERTRALINE HYDROCHLORIDE | SERTRALINE HYDROCHLORIDE | DIRECT RX | ab962a5a-fff6-2cf9-e053-2995a90ace0f | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | ANDA077206 312938 UTI8907Y6X |
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | c4bad433-623b-402c-b454-d39f19a23627 | 2025-01-14 | Boxed warning, Warnings, Adverse reactions | ANDA077206 312938 UTI8907Y6X |
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 0e5a7b02-3972-47f0-9f49-e958d792beac | 2025-01-14 | Boxed warning, Warnings, Adverse reactions | ANDA077206 312940 UTI8907Y6X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.